source
- Novo's M&A head joins Forbion as Perrigo CEO steps down over conduct concernsNovo's senior M&A executive has left the company to take a role at Dutch investment firm Forbion. Forbion, which manages a portfolio of biotech companies, has been active in M&A and aims to increa…
- Amgen seeks FDA review of Tavneos to determine continued market availabilityAmgen has formally asked the U.S. Food and Drug Administration to re-examine the data supporting its drug Tavneos (avacopan). Tavneos is indicated for a rare form of vasculitis and the request sig…